Items per page
1 - 192 of 192
Title Published in Access level OA Policy Year Views Downloads
Long-term levels of protection of different types of immunity against the Omicron variant : a rapid literature reviewSwiss medical weekly
accessLevelPublic
2024 25 10
Association of institutional masking policies with healthcare-associated SARS-CoV-2 infections in Swiss acute care hospitals during the BA.4/5 wave (CH-SUR study) : a retrospective observational studyAntimicrobial resistance and infection control
accessLevelPublic
2024 14 9
Factors Associated with Reliable Contact Tracing During the 2021 Ebola Virus Disease Outbreak in GuineaJournal of epidemiology and global health
accessLevelPublic
2024 107 15
Evaluating tuberculosis treatment outcomes in Haiti from 2018 to 2019 : A competing risk analysisIJID regions
accessLevelPublic
2024 34 9
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV) : a multicenter, international, non-randomized clinical trial study protocolBMC infectious diseases
accessLevelPublic
2024 22 10
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long‐Acting Intramuscular Injection in Real‐World People with HIVClinical pharmacology and therapeutics
accessLevelPublic
2024 6 5
Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3)The journal of infectious diseases
accessLevelPublic
2024 31 2
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral TherapyClinical infectious diseases
accessLevelPublic
2023 45 14
Analysis of global routine immunisation coverage shows disruption and stagnation during the first two-years of the COVID-19 pandemic with tentative recovery in 2022Vaccine. X
accessLevelPublic
2023 24 4
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV) : A Study Combining Modelling and Swiss HIV Cohort DataClinical infectious diseases
accessLevelPublic
2023 62 14
Investing in preparedness for rapid detection and control of epidemics: analysis of health system reforms and their effect on 2021 Ebola virus disease epidemic response in GuineaBMJ global health
accessLevelPublic
2023 302 61
Viral suppression and retention in HIV care during the postpartum period among women living with HIV : a longitudinal multicenter cohort studyThe Lancet regional health. Europe
accessLevelPublic
2023 15 2
Historical visit attendance as predictor of treatment interruption in South African HIV patients : Extension of a validated machine learning modelPLOS global public health
accessLevelPublic
2023 26 34
Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor‐containing regimenBritish journal of clinical pharmacology
accessLevelPublic
2023 58 15
External validation of the Dat'AIDS score : A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or olderHIV medicine
accessLevelPublic
2023 55 9
The spatial spread of HIV in Malawi : An individual-based mathematical modelHeliyon
accessLevelPublic
2023 30 15
An Automated Literature Review Tool (LiteRev) for Streamlining and Accelerating Research Using Natural Language Processing and Machine Learning: Descriptive Performance Evaluation StudyJMIR. Journal of medical internet research
accessLevelPublic
2023 87 21
Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV CoinfectionClinical infectious diseases
accessLevelRestricted
2023 78 0
COVID-19 preventive social-behavioural practices and exposure to SARS-CoV-2 among residents in the city of Yaounde : Lessons from the early phase of the pandemic in CameroonPLOS global public health
accessLevelPublic
2023 22 8
Differences between persons with and without disability in HIV prevalence, testing, treatment, and care cascade in Tanzania : a cross-sectional study using population-based dataBMC public health
accessLevelPublic
2023 34 13
Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort studyAIDS
accessLevelPublic
2023 63 9
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV : The Swiss HIV Cohort StudyThe Journal of infectious diseases
accessLevelPublic
2023 44 10
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)Open forum infectious diseases
accessLevelPublic
2023 18 10
Triggers of change in sexual behavior among people with HIV: The Swiss U = U statement and Covid-19 comparedThe journal of infectious diseases
accessLevelPublic
2023 52 22
A community-based contact isolation strategy to reduce the spread of Ebola virus disease: an analysis of the 2018-2020 outbreak in the Democratic Republic of the CongoBMJ global health
accessLevelPublic
2023 109 27
Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort StudyClinical infectious diseases
accessLevelPublic
2023 55 13
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)Open forum infectious diseases
accessLevelPublic
2023 16 9
Sexual Behaviour and STI Incidence in Sexually Active MSM Living With HIV in Times of COVID-19Open forum infectious diseases
accessLevelPublic
2023 52 14
Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018The journal of antimicrobial chemotherapy
accessLevelPublic
2023 53 33
Treatment effect of remdesivir on the mortality of hospitalised COVID-19 patients in Switzerland across different patient groups : a tree-based model analysisSwiss medical weekly
accessLevelPublic
2023 27 10
A Platform for Data-Centric, Continuous Epidemiological Analyses (EpiGraphHub) : Descriptive AnalysisJMIR. Journal of medical internet research
accessLevelPublic
2023 28 10
Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United StatesNew England journal of medicine
accessLevelRestricted
2022 37 0
Factors associated with the risk of HIV infection among HIV-exposed infants in Malawi : 2013-2020BMJ paediatrics open
accessLevelPublic
2022 24 3
COVID-19 in Switzerland real-time epidemiological analyses powered by EpiGraphHubScientific data
accessLevelPublic
2022 25 9
Associations of Sustainable Development Goals Accelerators With Adolescents' Well-Being According to Head-of-Household's Disability Status-A Cross-Sectional Study From ZambiaInternational journal of public health
accessLevelPublic
2022 137 59
Case Report: COVID-19 and Lassa Fever Coinfection in an Ebola Suspected Patient in GuineaThe American journal of tropical medicine and hygiene
accessLevelPublic
2022 262 94
CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort StudyJournal of acquired immune deficiency syndromes
accessLevelPublic
2022 40 4
Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19Euro surveillance
accessLevelPublic
2022 206 58
Time to death and risk factors associated with mortality among COVID-19 cases in countries within the WHO African region in the early stages of the COVID-19 pandemicEpidemiology and infection
accessLevelPublic
2022 165 77
Transfer of antiretroviral drugs into breastmilk : a prospective study from the Swiss Mother and Child HIV Cohort StudyJournal of antimicrobial chemotherapy
accessLevelPublic
2022 39 11
A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort StudyThe journal of infectious diseases
accessLevelRestricted
2022 57 0
An in-depth statistical analysis of the COVID-19 pandemic's initial spread in the WHO African regionBMJ global health
accessLevelPublic
2022 175 64
Factors associated with HIV viral suppression among children and adults receiving antiretroviral therapy in Malawi in 2021: Evidence from the Laboratory Management Information SystemTM & IH. Tropical medicine and international health
accessLevelPublic
2022 55 7
Diagnosis and case finding according to key partner risk populations of people living with HIV in Nigeria: A retrospective analysis of community-led index partner testing servicesEClinicalMedicine
accessLevelPublic
2022 475 96
COVID-19 pandemic in Africa's island nations during the first 9 months: a descriptive study of variation in patterns of infection, severe disease, and response measuresBMJ global health
accessLevelPublic
2022 110 74
Investigation of and Strategies to Control the Final Cluster of the 2018–2020 Ebola Virus Disease Outbreak in the Eastern Democratic Republic of CongoOpen forum infectious diseases
accessLevelPublic
2022 171 54
Prediction of HIV status based on socio-behavioural characteristics in East and Southern AfricaPloS one
accessLevelPublic
2022 143 67
Leveraging human resources for outbreak analysis: lessons from an international collaboration to support the sub-Saharan African COVID-19 responseBMC public health
accessLevelPublic
2022 214 35
Geospatial model of COVID-19 spreading and vaccination with event Gillespie algorithmNonlinear dynamics
accessLevelPublic
2022 144 55
A call for citizen science in pandemic preparedness and response: beyond data collectionBMJ global health
accessLevelPublic
2022 180 39
Quantifying and predicting ongoing Human Immunodeficiency Virus Type 1 (HIV-1) transmission dynamics in Switzerland using a distance-based clustering approachThe journal of infectious diseases
accessLevelRestricted
2022 81 2
A highly virulent variant of HIV-1 circulating in the NetherlandsScience
accessLevelPublic
2022 125 15
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patientsBMC infectious diseases
accessLevelPublic
2022 81 45
Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS)HIV medicine
accessLevelPublic
2022 58 14
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled TrialClinical infectious diseases
accessLevelPublic
2022 69 15
SARS-CoV-2 aerosol transmission in schools: the effectiveness of different interventionsSwiss medical weekly
accessLevelPublic
2022 174 89
Access to Social Protection by People Living with, at Risk of, or Affected by HIV in Eswatini, Malawi, Tanzania, and Zambia: Results from Population-Based HIV Impact AssessmentsAIDS and behavior
accessLevelPublic
2022 243 57
COVID-19 vaccines and post-vaccination data: Literature update (11) - 30.11.2021
accessLevelPublic
2021 320 97
Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)Swiss medical weekly
accessLevelPublic
2021 353 52
Analysing the reported incidence of COVID-19 and factors associated in the World Health Organization African region as of 31 December 2020Epidemiology and infection
accessLevelPublic
2021 221 64
COVID-19 in the WHO African Region: using risk assessment to inform decisions on public health and social measuresEpidemiology and infection
accessLevelPublic
2021 243 84
Information management practices in the WHO African Region to support response to the COVID-19 pandemicEpidemiology and Infection
accessLevelPublic
2021 188 47
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (10) - 15.12.2021
accessLevelPublic
2021 268 122
Insights into household transmission of SARS-CoV-2 from a population-based serological surveyNature Communications
accessLevelPublic
2021 310 87
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (Updated Version 7) - 02.11.2021
accessLevelPublic
2021 171 41
COVID-19 vaccines and post-vaccination data: Literature update (9) - 30.09.2021
accessLevelPublic
2021 228 50
The COVID-19 pandemic in the WHO African region: the first year (February 2020 to February 2021)Epidemiology and infection
accessLevelPublic
2021 343 66
Estimating the SARS-CoV2 infections detection rate and cumulative incidence in the World Health Organization African Region ten months into the pandemicEpidemiology and infection
accessLevelPublic
2021 201 45
COVID-19 mortality in women and men in sub-Saharan Africa: a cross-sectional studyBMJ global health
accessLevelPublic
2021 223 77
COVID-19 vaccines and post-vaccination data: Literature update (12) - 20.12.2021
accessLevelPublic
2021 187 47
Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort studySwiss medical weekly
accessLevelPublic
2021 261 80
Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort StudyOpen Forum Infectious Diseases
accessLevelPublic
2021 212 87
Clusters of sub-Saharan African countries based on sociobehavioural characteristics and associated HIV incidencePeerJ
accessLevelPublic
2021 438 122
Novel Use of Capture-Recapture Methods to Estimate Completeness of Contact Tracing during an Ebola Outbreak, Democratic Republic of the Congo, 2018-2020Emerging infectious diseases
accessLevelPublic
2021 204 60
The first eight months of COVID-19 pandemic in three West African countries: leveraging lessons learned from responses to the 2014-2016 Ebola virus disease outbreakEpidemiology and infection
accessLevelPublic
2021 242 69
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (8) - 15.11.2021
accessLevelPublic
2021 189 46
Recommandations pour le suivi des patients atteints d'hépatite C guérieSwiss Medical Forum
accessLevelPublic
2021 185 109
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (4) - 13.09.2021
accessLevelPublic
2021 181 55
Evidence-based Definition for Extensively Drug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine
accessLevelPublic
2021 259 171
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (6) - 15.10.2021
accessLevelPublic
2021 177 91
Implementing epidemic intelligence in the WHO African region for early detection and response to acute public health eventsEpidemiology and Infection
accessLevelPublic
2021 225 81
Assessing relative COVID-19 mortality: a Swiss population-based studyBMJ Open
accessLevelPublic
2021 354 67
Women with disabilities in hearing: the last mile in the elimination of mother-to-child transmission of HIV - a cross-sectional study from ZambiaAIDS care
accessLevelPublic
2021 189 67
Monitoring and Evaluation of COVID-19 response in the WHO African Region: challenges and lessons learnedEpidemiology and Infection
accessLevelPublic
2021 264 113
The role of children and adolescents in the SARS-CoV-2 pandemic: a rapid reviewSwiss medical weekly
accessLevelPublic
2021 270 92
COVID-19 vaccines and post-vaccination data: Literature update (Updated Version 10) - 02.11.2021
accessLevelPublic
2021 206 42
Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in SwitzerlandSwiss Medical Weekly
accessLevelPublic
2021 286 115
Tuberculosis in the Western Pacific Region: Estimating the burden of disease and return on investment 2020–2030 in four countriesThe Lancet Regional Health - Western Pacific
accessLevelPublic
2021 162 68
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (2) - 16.08.2021
accessLevelPublic
2021 164 39
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (3) - 30.08.2021
accessLevelPublic
2021 163 34
Evaluation of Early Warning, Alert and Response system for Ebola virus disease, Democratic Republic of the Congo, 2018–2020Emerging infectious diseases
accessLevelPublic
2021 313 85
COVID-19 vaccines and post-vaccination data: literature update (8) - 30.08.2021
accessLevelPublic
2021 272 55
Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysisPeerJ
accessLevelPublic
2021 259 62
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in CameroonNature communications
accessLevelPublic
2021 210 84
Assessing relative COVID-19 mortality during the second wave: a prospective Swiss population-based studyBMJ open
accessLevelPublic
2021 160 56
A public health strategy for SARS-CoV-2, grounded in science, should guide Swiss schools through the coming winterSwiss medical weekly
accessLevelPublic
2021 310 102
Geographical Disparities in HIV Seroprevalence Among Men Who Have Sex with Men and People Who Inject Drugs in Nigeria: Exploratory Spatial Data AnalysisJMIR Public Health and Surveillance
accessLevelPublic
2021 252 232
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (9) - 30.11.2021
accessLevelPublic
2021 174 79
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (5) - 30.09.2021
accessLevelPublic
2021 175 68
Systematic review of Integrated Disease Surveillance and Response (IDSR) implementation in the African regionPLOS ONE
accessLevelPublic
2021 270 147
Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort StudyThe journal of infectious diseases
accessLevelPublic
2021 59 6
Facing the quality of life: physical illness, anxiety, and depression symptoms among people living with HIV in rural Zambia - a cross-sectional studyAIDS care
accessLevelPublic
2021 165 175
The toll of COVID-19 on African children: A descriptive analysis on the COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan AfricaInternational Journal of Infectious Diseases
accessLevelPublic
2021 166 93
The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort StudyJournal of clinical medicine
accessLevelPublic
2021 37 7
Precision global health: a roadmap for augmented actionJournal of Public Health and Emergency
accessLevelPublic
2020 875 341
Identifying groups of people with similar sociobehavioural characteristics in Malawi to inform HIV interventions: a latent class analysisJournal of the International AIDS society
accessLevelPublic
2020 242 78
Zimbabwe's national third-line antiretroviral therapy program: Cohort description and treatment outcomesPLOS ONE
accessLevelPublic
2020 191 90
Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort StudyClinical Infectious Diseases
accessLevelRestricted
2020 177 0
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studyThe Lancet
accessLevelRestricted
2020 651 14
Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIVPLoS biology
accessLevelPublic
2020 48 8
Future scenarios for the SARS-CoV-2 epidemic in Switzerland: an age-structured modelF1000Research
accessLevelPublic
2020 304 42
Mortality trends and causes of death among HIV positive patients at Newlands Clinic in Harare, ZimbabwePLOS ONE
accessLevelPublic
2020 226 93
Use of electronic tools for evidence-based preparedness and response to the COVID-19 pandemic in the WHO African regionThe Lancet Digital Health
accessLevelPublic
2020 221 74
Social determinants of male partner attendance in women's prevention-of mother-to-child transmission program in MalawiBMC Public Health
accessLevelPublic
2020 208 68
Social, Behavioral, and Cultural factors of HIV in Malawi: Semi-Automated Systematic ReviewJournal of Medical Internet Research
accessLevelPublic
2020 246 511
Measuring Timeliness of Outbreak Response in the World Health Organization African Region, 2017-2019Emerging Infectious Diseases
accessLevelPublic
2020 251 62
How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?HIV medicine
accessLevelPublic
2020 57 9
Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral TherapyOpen Forum Infectious Diseases
accessLevelPublic
2020 161 83
All-Cause mortality and causes of death in the Swiss Hepatitis C Cohort Study (SCCS)Open Forum Infectious Diseases
accessLevelPublic
2020 299 138
Variations in tuberculosis prevalence, russian federation: a multivariate approachBulletin of the World Health Organization
accessLevelPublic
2019 397 257
Precision Global Health - The case of Ebola: a scoping reviewJournal of Global Health
accessLevelPublic
2019 563 245
Modelling the impact of different testing strategies for HCV infection in switzerlandJournal of virus eradication
accessLevelPublic
2019 294 70
Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in Southern Africa: health economic and modelling analysisJournal of the International AIDS society
accessLevelPublic
2019 340 186
Long-term retention on antiretroviral therapy among infants, children, adolescents and adults in Malawi: A cohort studyPLOS ONE
accessLevelPublic
2019 249 107
Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort StudyPLOS ONE
accessLevelPublic
2019 399 185
Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherenceThe journal of antimicrobial chemotherapy
accessLevelRestricted
2019 44 0
"I do all I can but I still fail them": Health system barriers to providing Option B+ to pregnant and lactating women in MalawiPLOS ONE
accessLevelPublic
2019 322 147
Changing trends in international versus domestic HCV transmission in HIV-positive MSM: A perspective for the DAA scale-up eraThe Journal of Infectious Diseases
accessLevelPublic
2019 737 203
A case report of untreatable HIV infection in Harare, ZimbabweSouthern African Journal of HIV Medicine
accessLevelPublic
2019 300 118
Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017Journal of the International AIDS society
accessLevelPublic
2019 310 126
Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?Clinical Infectious Diseases
accessLevelPublic
2019 449 134
Programme national de lutte contre le VIH, les IST et l'hépatite virale: unir les forces contre le VIH et les hépatites viralesBulletin des médecins suisses
accessLevelPublic
2019 377 149
Research priorities to inform "Treat All" policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA)Journal of the International AIDS society
accessLevelPublic
2019 695 357
Timing of combination antiretroviral therapy (cART) initiation is not associated with stillbirth among HIV-infected pregnant women in MalawiTropical Medicine & International Health
accessLevelPublic
2019 410 189
Socio‐behavioural characteristics and HIV: findings from a graphical modelling analysis of 29 sub‐Saharan African countriesJournal of the International AIDS society
accessLevelPublic
2019 321 140
Why do sub‐Saharan Africans present late for HIV care in Switzerland ?HIV medicine
accessLevelRestricted
2019 41 0
On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling studyJournal of viral hepatitis
accessLevelPublic
2018 1 651 420
How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countriesJournal of the International AIDS society
accessLevelPublic
2018 567 227
Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviourJournal of the International AIDS society
accessLevelPublic
2018 1 576 344
Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)-Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination ScheduleClinical infectious diseases
accessLevelRestricted
2018 40 0
Patterns of caesarean section in HIV infected and non-infected women in Malawi: is caesarean section used for PMTCT?BMC Pregnancy and Childbirth
accessLevelPublic
2018 437 158
Impact of Screening and Treatment for Hepatitis C Virus (HCV) Infection in Switzerland. A Comprehensive Mathematical Model of the Swiss HCV Epidemic
accessLevelPublic
2018 473 108
The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDSThe Lancet HIV
accessLevelPublic
2018 1 113 397
Mathematical modelling to inform 'treat all' implementation in sub-Saharan Africa: a scoping reviewJournal of Virus Eradication
accessLevelPublic
2018 345 90
The Effect of Monitoring Viral Load and Tracing Patients Lost to Follow-up on the Course of the HIV Epidemic in Malawi: A Mathematical ModelOpen Forum Infectious Diseases
accessLevelPublic
2018 1 446 311
Combler les lacunes dans les tests de dépistage de l'hépatiteBulletin des médecins suisses
accessLevelPublic
2018 413 149
HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in ZimbabweOpen Forum Infectious Diseases
accessLevelPublic
2018 543 187
Weight gain of HIV-exposed, uninfected children born before and after introduction of the "Option B+" programme in MalawiAIDS
accessLevelPublic
2018 385 155
Cohort profile: The MULTI sTUdy Diabetes rEsearch (MULTITUDE) consortiumBMJ Open
accessLevelPublic
2018 483 170
Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysisClinical Infectious Diseases
accessLevelPublic
2018 428 136
Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative personsEuropean heart journal
accessLevelRestricted
2018 57 0
A community outbreak of Legionnaires' disease in Geneva, Switzerland, June to September 2017Swiss Medical Weekly
accessLevelPublic
2018 435 208
"I found that I was well and strong": Women's motivations for remaining on ART under Option B+ in MalawiPLOS ONE
accessLevelPublic
2018 496 170
HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programmeJournal of the International AIDS society
accessLevelPublic
2017 512 266
The cascade of care to prevent mother-to-child transmission in Rio de Janeiro, Brazil, 1996-2013: improving but still some way to goTropical Medicine & International Health
accessLevelPublic
2017 460 316
New-onset type 2 diabetes mellitus among patients receiving HIV care at Newlands Clinic, Harare, Zimbabwe: retrospective cohort analysisTropical Medicine & International Health
accessLevelPublic
2017 522 212
Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemicsPLOS ONE
accessLevelPublic
2017 478 219
Trends in hepatitis C-related mortality in SwitzerlandJournal of Hepatology
accessLevelPublic
2017 1 141 579
Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSMAIDS
accessLevelPublic
2017 538 277
The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular EventsJournal of acquired immune deficiency syndromes
accessLevelRestricted
2016 42 0
Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy : The Swiss HIV Cohort StudyOpen forum infectious diseases
accessLevelPublic
2016 40 6
Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventionsHepatology
accessLevelPublic
2016 642 214
Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening RecommendationsPloS one
accessLevelPublic
2016 553 508
Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort studyInternational journal of cancer
accessLevelPublic
2016 584 226
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort AnalysisClinical Infectious Diseases
accessLevelRestricted
2016 614 1
HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort StudyClinical Infectious Diseases
accessLevelPublic
2016 450 141
Increases in Condomless Sex in the Swiss HIV Cohort StudyOpen forum infectious diseases
accessLevelPublic
2015 52 10
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort StudyBMC infectious diseases
accessLevelPublic
2015 56 9
Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in SwitzerlandAIDS
accessLevelRestricted
2015 49 0
Reasons for late presentation to HIV care in SwitzerlandJournal of the International AIDS Society
accessLevelPublic
2015 39 3
Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort StudyJournal of acquired immune deficiency syndromes
accessLevelPublic
2015 54 8
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected personsBMC gastroenterology
accessLevelPublic
2015 39 5
Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortalityAIDS
accessLevelRestricted
2015 44 0
Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in ZambiaClinical infectious diseases
accessLevelPublic
2014 676 228
Social Meets Molecular: Combining Phylogenetic and Latent Class Analyses to Understand HIV-1 Transmission in SwitzerlandAmerican journal of epidemiology
accessLevelPublic
2014 780 25
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backboneHIV clinical trials
accessLevelRestricted
2014 42 0
Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort StudyAmerican journal of epidemiology
accessLevelRestricted
2013 573 0
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infectionBritish journal of cancer
accessLevelPublic
2012 505 1 042
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort StudyJournal of acquired immune deficiency syndromes
accessLevelRestricted
2012 563 0
Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and SwitzerlandPloS one
accessLevelPublic
2011 1 209 341
Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients : The ACHIEV2E Collaboration Study GroupClinical infectious diseases
accessLevelRestricted
2011 53 0
A randomized crossover study to compare efavirenz and etravirine treatmentAIDS
accessLevelRestricted
2011 58 0
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapyGut
accessLevelRestricted
2010 572 0
Pregnancy and delivery outcomes of HIV infected women in Switzerland 2003-2008Journal of perinatal medicine
accessLevelRestricted
2010 594 0
Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008The American journal of psychiatry
2010 623 0
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort StudyBritish journal of cancer
accessLevelRestricted
2010 728 1
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort StudyHIV medicine
accessLevelRestricted
2009 568 0
Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland comparedPLoS medicine
accessLevelPublic
2008 783 350
Antiretroviral treatment during pregnancyAIDS
accessLevelRestricted
2008 610 0
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort StudyThe Journal of infectious diseases
accessLevelRestricted
2008 579 0
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patientsJournal of viral hepatitis
accessLevelRestricted
2008 578 0
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modificationAntiviral therapy
accessLevelRestricted
2007 523 1
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack